Total Payments
$1,451
2024 Payments
$240.03
Companies
7
Transactions
26
Medicare Patients
616
Medicare Billing
$62,615
Payment Breakdown by Category
Food & Beverage$1,451 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,451 | 26 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | $363.84 | 8 | $0 (2022) |
| ABBVIE INC. | $327.77 | 5 | $0 (2024) |
| Merck Sharp & Dohme LLC | $203.51 | 2 | $0 (2023) |
| ViiV Healthcare Company | $184.50 | 2 | $0 (2022) |
| Gilead Sciences, Inc. | $183.86 | 7 | $0 (2024) |
| GlaxoSmithKline, LLC. | $124.99 | 1 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $62.73 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $240.03 | 5 | GlaxoSmithKline, LLC. ($124.99) |
| 2023 | $318.97 | 5 | AbbVie Inc. ($142.53) |
| 2022 | $545.98 | 9 | Janssen Scientific Affairs, LLC ($214.64) |
| 2021 | $258.00 | 6 | Janssen Scientific Affairs, LLC ($149.20) |
| 2019 | $88.22 | 1 | Merck Sharp & Dohme Corporation ($88.22) |
All Payment Transactions
26 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/14/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/24/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: VACCINES | ||||||
| 03/20/2024 | ABBVIE INC. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $44.40 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/06/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $27.89 | General |
| 03/05/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $26.68 | General |
| 10/03/2023 | AbbVie Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $98.61 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/31/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $34.55 | General |
| 07/26/2023 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $43.92 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/16/2023 | Merck Sharp & Dohme LLC | RECARBRIO (Drug) | Food and Beverage | In-kind items and services | $115.29 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/31/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $26.60 | General |
| 11/04/2022 | Janssen Scientific Affairs, LLC | SYMTUZA (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 10/20/2022 | Ferring Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $62.73 | General |
| 10/20/2022 | Janssen Scientific Affairs, LLC | — | Food and Beverage | In-kind items and services | $17.72 | General |
| 10/13/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $18.57 | General |
| 09/06/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $25.27 | General |
| 07/26/2022 | Janssen Scientific Affairs, LLC | CABENUVA (Drug) | Food and Beverage | In-kind items and services | $122.92 | General |
| Category: Infectious Diseases | ||||||
| 06/14/2022 | Janssen Scientific Affairs, LLC | CABENUVA (Drug) | Food and Beverage | In-kind items and services | $55.87 | General |
| Category: Infectious Diseases | ||||||
| 03/31/2022 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: HIV | ||||||
| 03/16/2022 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $124.77 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/07/2021 | Janssen Scientific Affairs, LLC | Cabenuva (Drug) | Food and Beverage | In-kind items and services | $67.76 | General |
| Category: Infectious Diseases | ||||||
| 10/15/2021 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $24.30 | General |
| 10/11/2021 | Janssen Scientific Affairs, LLC | Cabenuva (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Infectious Diseases | ||||||
| 07/28/2021 | Janssen Scientific Affairs, LLC | Cabenuva (Drug) | Food and Beverage | In-kind items and services | $21.70 | General |
| Category: Infectious Diseases | ||||||
| 07/22/2021 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $84.50 | General |
| Category: HIV | ||||||
| 07/13/2021 | Janssen Scientific Affairs, LLC | Cabenuva (Drug) | Food and Beverage | In-kind items and services | $42.74 | General |
| Category: Infectious Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 145 | 184 | $35,379 | $14,096 |
| 2022 | 5 | 135 | 167 | $36,010 | $13,757 |
| 2021 | 6 | 192 | 228 | $48,704 | $18,673 |
| 2020 | 5 | 144 | 203 | $41,270 | $16,089 |
Total Patients
616
Total Services
782
Medicare Billing
$62,615
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 47 | 47 | $13,019 | $4,716 | 36.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 32 | 42 | $8,894 | $3,763 | 42.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 35 | 53 | $7,897 | $3,236 | 41.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 19 | 25 | $5,370 | $2,237 | 41.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 12 | 17 | $199.00 | $142.80 | 71.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 40 | 41 | $11,357 | $4,240 | 37.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 48 | 72 | $10,728 | $3,966 | 37.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 21 | 28 | $5,852 | $2,545 | 43.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 13 | 13 | $5,291 | $1,982 | 37.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 13 | 13 | $2,782 | $1,025 | 36.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 48 | 49 | $13,573 | $5,103 | 37.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 48 | 68 | $10,132 | $3,731 | 36.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 31 | 36 | $7,524 | $3,261 | 43.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 31 | 39 | $8,346 | $3,090 | 37.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 15 | 15 | $6,105 | $2,303 | 37.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 19 | 21 | $3,024 | $1,186 | 39.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 54 | 102 | $14,955 | $5,755 | 38.5% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 35 | 35 | $9,640 | $3,748 | 38.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 21 | 22 | $8,772 | $3,467 | 39.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 17 | 25 | $5,182 | $2,033 | 39.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 17 | 19 | $2,721 | $1,087 | 39.9% |
About Pamela Bailey
Pamela Bailey is a Infectious Disease healthcare provider based in Columbia, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/16/2014. The National Provider Identifier (NPI) number assigned to this provider is 1730509829.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Pamela Bailey has received a total of $1,451 in payments from pharmaceutical and medical device companies, with $240.03 received in 2024. These payments were reported across 26 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($1,451).
As a Medicare-enrolled provider, Bailey has provided services to 616 Medicare beneficiaries, totaling 782 services with total Medicare billing of $62,615. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Location Columbia, SC
- Active Since 04/16/2014
- Last Updated 06/05/2020
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1730509829
Products in Payments
- DALVANCE (Drug) $184.76
- CABENUVA (Biological) $184.50
- CABENUVA (Drug) $178.79
- Cabenuva (Drug) $149.20
- SHINGRIX (Biological) $124.99
- RECARBRIO (Drug) $115.29
- TEFLARO (Drug) $98.61
- ZINPLAVA (Biological) $88.22
- AVYCAZ (Drug) $44.40
- SYMTUZA (Drug) $18.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Columbia
Dr. Phillip Beck, M.d, M.D
Infectious Disease — Payments: $5,742
Infectious Disease $5,742
Dr. Robert Ross, M.d, M.D
Infectious Disease — Payments: $3,320
Infectious Disease $3,320
Dr. Eric Brener, M.d, M.D
Infectious Disease — Payments: $2,753
Infectious Disease $2,753
Harmeet Gill, Md, MD
Infectious Disease — Payments: $1,836
Infectious Disease $1,836
Amy Bowers, Do, DO
Infectious Disease — Payments: $1,227
Infectious Disease $1,227
Tameka Funny, D.o, D.O
Infectious Disease — Payments: $1,172
Infectious Disease $1,172